Tianjin Chasesun Pharmaceutical Co., LTD

Quick facts

Phase 2 pipeline

• 16mg，KB
  KB is a small molecule drug that targets the mechanism of action of the drug.

Phase 1 pipeline

• Kukoamine B Mesilate

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Tianjin Chasesun Pharmaceutical Co., LTD portfolio CI brief
• Tianjin Chasesun Pharmaceutical Co., LTD pipeline updates RSS

Related

• Sector hub: All tracked pharma companies